Cargando…

Adsorption of Phenazines Produced by Pseudomonas aeruginosa Using AST-120 Decreases Pyocyanin-Associated Cytotoxicity

AST-120 (Kremezin) is used to treat progressive chronic kidney disease by adsorbing uremic toxin precursors produced by the gut microbiota, such as indole and phenols. Previously, we found that AST-120 decreased drug tolerance and virulence in Escherichia coli by adsorbing indole. Here, we show that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hirakawa, Hidetada, Takita, Ayako, Uchida, Motoyuki, Kaneko, Yuka, Kakishima, Yuto, Tanimoto, Koichi, Kamitani, Wataru, Tomita, Haruyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068879/ https://www.ncbi.nlm.nih.gov/pubmed/33924459 http://dx.doi.org/10.3390/antibiotics10040434

Ejemplares similares

In vitro activity of AST-120 that suppresses indole signaling in Escherichia coli, which attenuates drug tolerance and virulence
por: Hirakawa, Hidetada, et al.
Publicado: (2020)

Adsorption of extracellular proteases and pyocyanin produced by Pseudomonas aeruginosa using a macroporous magnesium oxide-templated carbon decreases cytotoxicity
por: Hirakawa, Hidetada, et al.
Publicado: (2022)

A Macroporous Magnesium Oxide-Templated Carbon Adsorbs Shiga Toxins and Type III Secretory Proteins in Enterohemorrhagic Escherichia coli, Which Attenuates Virulence
por: Hirakawa, Hidetada, et al.
Publicado: (2022)

Roles of OmpA in Type III Secretion System-Mediated Virulence of Enterohemorrhagic Escherichia coli
por: Hirakawa, Hidetada, et al.
Publicado: (2021)

Roles of the Tol-Pal system in the Type III secretion system and flagella-mediated virulence in enterohemorrhagic Escherichia coli
por: Hirakawa, Hidetada, et al.
Publicado: (2020)

Oxygen Limitation Enhances the Antimicrobial Activity of Fosfomycin in Pseudomonas aeruginosa Following Overexpression of glpT Which Encodes Glycerol-3-Phosphate/Fosfomycin Symporter
por: Hirakawa, Hidetada, et al.
Publicado: (2018)

Cooperative Actions of CRP-cAMP and FNR Increase the Fosfomycin Susceptibility of Enterohaemorrhagic Escherichia coli (EHEC) by Elevating the Expression of glpT and uhpT under Anaerobic Conditions
por: Kurabayashi, Kumiko, et al.
Publicado: (2017)

Interference of bacterial cell-to-cell communication: a new concept of antimicrobial chemotherapy breaks antibiotic resistance
por: Hirakawa, Hidetada, et al.
Publicado: (2013)

Roles of the Tol/Pal System in Bacterial Pathogenesis and Its Application to Antibacterial Therapy
por: Hirakawa, Hidetada, et al.
Publicado: (2022)

Editorial: Gram-Negative Pathogenesis
por: Hirakawa, Hidetada, et al.
Publicado: (2021)

Inactivation of ackA and pta Genes Reduces GlpT Expression and Susceptibility to Fosfomycin in Escherichia coli
por: Hirakawa, Hidetada, et al.
Publicado: (2023)

The PapB/FocB family protein TosR acts as a positive regulator of flagellar expression and is required for optimal virulence of uropathogenic Escherichia coli
por: Hirakawa, Hidetada, et al.
Publicado: (2023)

The Tol-Pal System of Uropathogenic Escherichia coli Is Responsible for Optimal Internalization Into and Aggregation Within Bladder Epithelial Cells, Colonization of the Urinary Tract of Mice, and Bacterial Motility
por: Hirakawa, Hidetada, et al.
Publicado: (2019)

Progress Overview of Bacterial Two-Component Regulatory Systems as Potential Targets for Antimicrobial Chemotherapy
por: Hirakawa, Hidetada, et al.
Publicado: (2020)

Effect of AST-120 on Endothelial Dysfunction in Adenine-Induced Uremic Rats
por: Inami, Yuko, et al.
Publicado: (2014)

Elucidation of host diversity of the VanD-carrying genomic islands in enterococci and anaerobes
por: Hashimoto, Yusuke, et al.
Publicado: (2022)

AST-120 for the management of progression of chronic kidney disease
por: Schulman, Gerald, et al.
Publicado: (2014)

First Report of the Local Spread of Vancomycin-Resistant Enterococci Ascribed to the Interspecies Transmission of a vanA Gene Cluster-Carrying Linear Plasmid
por: Hashimoto, Yusuke, et al.
Publicado: (2020)

Novel Multidrug-Resistant Enterococcal Mobile Linear Plasmid pELF1 Encoding vanA and vanM Gene Clusters From a Japanese Vancomycin-Resistant Enterococci Isolate
por: Hashimoto, Yusuke, et al.
Publicado: (2019)

AST-120 Reduces Neuroinflammation Induced by Indoxyl Sulfate in Glial Cells
por: Adesso, Simona, et al.
Publicado: (2018)

The Uremic Toxin Adsorbent AST-120 Abrogates Cardiorenal Injury Following Myocardial Infarction
por: Lekawanvijit, Suree, et al.
Publicado: (2013)

Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120
por: Velenosi, Thomas J., et al.
Publicado: (2016)

Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120
por: Schulman, Gerald, et al.
Publicado: (2017)

Importance of AST-120 (Kremezin®) Adherence in a Chronic Kidney Disease Patient with Diabetes
por: Tomino, Yasuhiko, et al.
Publicado: (2018)

Review of the efficacy of AST-120 (KREMEZIN(®)) on renal function in chronic kidney disease patients
por: Asai, Mayumi, et al.
Publicado: (2019)

Prediction of Patients Who Can Benefit from Oral Intestinal Sorbent AST-120
por: Cha, Ran-hui
Publicado: (2019)

PYOCYANINE, AN ACCESSORY RESPIRATORY ENZYME
por: Friedheim, Ernst A. H.
Publicado: (1931)

Prediction of drug interaction between oral adsorbent AST-120 and concomitant drugs based on the in vitro dissolution and in vivo absorption behavior of the drugs
por: Koya, Yohei, et al.
Publicado: (2016)

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease
por: Hatakeyama, Shingo, et al.
Publicado: (2012)

Finding phenazine
por: Wolfson, Sarah J, et al.
Publicado: (2020)

Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques
por: Sato, Emiko, et al.
Publicado: (2017)

AST-120 Improves Microvascular Endothelial Dysfunction in End-Stage Renal Disease Patients Receiving Hemodialysis
por: Ryu, Jung-Hwa, et al.
Publicado: (2016)

Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
por: Liu, Wen-Chih, et al.
Publicado: (2018)

Oral adsorbent AST-120 ameliorates gut environment and protects against the progression of renal impairment in CKD rats
por: Yoshifuji, Ayumi, et al.
Publicado: (2018)

Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease
por: Nagata, Daisuke, et al.
Publicado: (2020)

Efficacy of AST-120 for Patients With Chronic Kidney Disease: A Network Meta-Analysis of Randomized Controlled Trials
por: Su, Pei-Yu, et al.
Publicado: (2021)

Effects of AST‐120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study
por: Cha, Ran‐hui, et al.
Publicado: (2021)

Unsuspected pyocyanin effect in yeast under anaerobiosis
por: Barakat, Rana, et al.
Publicado: (2014)

Standardized chemical synthesis of Pseudomonas aeruginosa pyocyanin
por: Cheluvappa, Rajkumar
Publicado: (2014)

Pyocyanin Restricts Social Cheating in Pseudomonas aeruginosa
por: Castañeda-Tamez, Paulina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ssa0sq5g89nuhfhmegjlch3d4b